Join

Compare · AKYA vs BIO

AKYA vs BIO

Side-by-side comparison of Akoya BioSciences Inc. (AKYA) and Bio-Rad Laboratories Inc. (BIO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKYA and BIO operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • BIO is the larger of the two at $8.36B, about 21.5x AKYA ($388.8M).
  • Over the past year, AKYA is up 5.3% and BIO is up 43.9% - BIO leads by 38.6 points.
  • BIO has hit the wire 1 time in the past 4 weeks while AKYA has been quiet.
  • AKYA has more recent analyst coverage (13 ratings vs 12 for BIO).
PerformanceAKYA+5.26%BIO+8.65%
2025-06-02+0.00%2025-07-07
MetricAKYABIO
Company
Akoya BioSciences Inc.
Bio-Rad Laboratories Inc.
Price
$1.30-5.80%
$311.89-1.93%
Market cap
$388.8M
$8.36B
1M return
+11.11%
+13.38%
1Y return
+5.26%
+43.89%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NYSE
IPO
2021
1980
News (4w)
0
1
Recent ratings
13
12
AKYA

Akoya BioSciences Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

BIO

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Latest AKYA

Latest BIO